about
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesNew oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsEducational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trialLegal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapyA heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparinParenteral anticoagulation in ambulatory patients with cancerEfficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled TrialsAn economic model of adverse events and costs for oral anticoagulants used for atrial fibrillationAntiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmAntiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeAnticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney diseaseAntiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndromeAnticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repairAnticoagulant treatment for subsegmental pulmonary embolismAnticoagulants for acute ischaemic strokeAnticoagulation for people receiving long-term haemodialysisNew oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney diseaseAnticoagulation for people with cancer and central venous cathetersAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationAnticoagulation therapy versus placebo for pulmonary hypertensionVitamin K for improved anticoagulation control in patients receiving warfarinAnticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudicationAnticoagulation for the long-term treatment of venous thromboembolism in patients with cancerOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationAnticoagulant treatment for subsegmental pulmonary embolismSecondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolismAnticoagulant treatment for subsegmental pulmonary embolismAnticoagulation versus placebo for heart failure in sinus rhythmAnticoagulation therapy versus placebo for pulmonary hypertensionAntiplatelet and anticoagulation for patients with prosthetic heart valvesAntiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatmentOptimal loading dose of warfarin for the initiation of oral anticoagulationEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationAnticoagulation versus placebo for heart failure in sinus rhythmVitamin K for improved anticoagulation control in patients receiving warfarinLow molecular weight heparin (LMWH) versus unfractionated heparin (UFH) for haemodialysis anticoagulationAnticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney diseaseOral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillationAnticoagulation for the initial treatment of venous thromboembolism in patients with cancer
P921
Q21090750-C5B2873B-2B25-4AF6-8A6C-B16748CBC347Q21132464-7723CF18-72EC-4EB2-BD5D-A843695E49C8Q21132512-3C904059-7448-411B-A973-5FAFF4501C7FQ21146694-F239317E-D187-410E-97AF-82A866D5822AQ21245645-0DBC0B67-0B86-4119-85D3-F561B1B95D8FQ22252972-BBBEC505-9634-401A-A94B-25B981B27125Q22306362-8F534E01-63CE-4ACB-8897-CF05ABFCD33AQ23914009-020D9C1C-C81A-4AE9-9CE1-9650FF46D8F4Q24185800-15926766-F277-4602-AAA1-B6AA3C542C8EQ24185813-7C5E0CF8-784F-4626-815E-5C2E461197C3Q24185924-4E230B0F-148A-498F-B94A-8AC9D5A0F08BQ24185949-D254767C-DD7C-47E1-B3A9-5759B0548D89Q24185998-E84A3CB9-4476-47E4-8528-B946F684FEDDQ24186514-8E8AE3CE-4763-4335-8072-54826EDE9192Q24187310-11382C64-13F7-4BC2-A10A-5A3B4521EB3DQ24187603-AB71C34B-2A76-4822-B77F-36DA946165D3Q24192938-A717BBCF-19D5-4B1B-A08E-363E97D64103Q24193103-7FF5A92F-C102-4F5D-95BD-A7A8100AAC4DQ24193871-81950033-5BA4-430A-9D59-E3C34EF608E1Q24194116-A1396D02-ED98-4952-830D-E5D68483BA9DQ24194138-9D3BA98D-47D5-4963-A58A-BC925B417849Q24194649-F15AB89A-C4A2-4E0E-AE62-7064B1AD3D49Q24194752-466F6C87-CC3E-40EF-98AA-0D7E8387A3D4Q24194904-ECFF1E0C-4D14-43F2-8485-0E009D52EEA6Q24194926-6AB2C568-D4DC-4F8A-8869-FE34E90014FBQ24194990-CD1EB13A-DA0F-4D25-909A-51DC6EE81D32Q24197581-DD77B7BC-08F2-4633-91F2-8CC0CBB0DC8BQ24197722-BD93636A-60E7-4F73-A58F-B353EC88854DQ24197822-E826457F-D2AC-4D78-A034-D9672EB75D68Q24200875-9DF45F1D-2E2F-4BDC-90D3-8D1458437A9EQ24201287-6FEC4B1A-5C2C-43DC-A56C-176073EED3F9Q24201432-7F172E4D-A1E5-4AB5-9A9D-8C778FF31DDBQ24202077-C6C66D69-EA8E-47AE-BA80-833063D03983Q24202280-4CC81FC8-8C28-4DA3-92D0-4BEBD3D985EFQ24202686-F00669E6-DC58-4FA3-A2A6-29AB0F239DEFQ24202915-7735A1D2-8BAF-4DD8-8251-13768677AFC5Q24203624-F4CCC13A-895C-4F48-B1FC-C73D7CF06A2CQ24203776-B5812C66-BDF1-4A47-865E-83828230232BQ24203797-2390F980-35BD-49F5-90B4-110F9874772EQ24234155-AAA72D05-4F3B-4A18-9E1E-992496D75F9E
P921
description
set of mechanisms to prevent blood from thickening
@en
name
anticoagulación
@es
anticoagulation
@en
type
label
anticoagulación
@es
anticoagulation
@en
prefLabel
anticoagulación
@es
anticoagulation
@en